Combining the results of the negative likelihood ratio (DLR NEG = 0.21 [0.10–0.43]) and positive likelihood ratio (DLR POS = 5.09 [2.29–11.33]), ESPL1 expression was able to distinguish BC patients with higher precision. The gene discussed is ESPL1; the disease is breast cancer.